causal

Pharma Gains from Diagnosing Hard-to-Find Disease

Better AI diagnosis of a disease that is not very rare but hard to identify would let pharmaceutical companies sell far more of an existing drug, increasing profits and helping more patients, because the bottleneck is identifying who needs the drug rather than producing it.

causalpending

Speaker

Avi Goldfarb

Evidence Quote

“any production capacity on that kind of a drug becomes much, much more profitable.”

Source

Avi Goldfarb - The Economic Impact of AI - [Invest Like the Best, EP.321]— Invest Like the Best
Created: 11/14/2026, 4:33:04 AM

Your notes

Loading notes...